LENZ Therapeutics, Inc.

LENZ Stock Healthcare Biotechnology
$3.27
-0.30 (-8.40%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-20.8%
3 Months
-34.1%
YTD
-79.6%
1 Year
-92.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
79.8%
Largest decline max drawdown, since Oct 2025
-93.3%
Risk-adjusted return Sharpe ratio, 1-year
-2.76

Own LENZ?

See how LENZ contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.